Administration of betaHCG leads to dose-dependent changes of gene expression signature of endometriotic stromal cells

Gernot Hudelist, Hudelist G, Ambros Huber, Huber A, Michael Auer, Auer M, Martin Knöfler, Knöfler M, Saleh L, Leila Saleh, Hrachowitz C, Christian Hrachowitz, Johannes Huber, Huber JC, Johannes C. Huber, Kubista E, Ernst Kubista, E. Kubista, M. Manavi, Mahmood Manavi, Manavi M, Martin Bilban, Christian F. Singer, Singer CF
Reproductive BioMedicine Online · 2010 · vol. 20(5) , pp. 699–706 · doi:10.1016/j.rbmo.2010.01.010 · PMID:20395176 · W2077784786
Lab / animal OA: closed CC0 ⤵ 1 in-corpus citation
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-08 ⓘ

Human chorionic gonadotropin (βHCG) administration induced dose-dependent alterations in the gene expression profiles of human endometriotic stromal cells.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Preliminary studies have shown that systemic beta-human chorionic gonadotrophin (betaHCG) therapy alleviates endometriosis-related chronic pelvic pain. The underlying mechanism, however, is completely unknown. This study has investigated the dose-dependent alterations in the overall gene expression profile of endometriosis-derived stromal cells under increasing concentrations of betaHCG by using the Affymetrix GeneChip U133 Set. It has been previously shown that betaHCG concentrations of 0.1U/ml and higher lead to a significant and dose-dependent increase in the expression of 68 genes. This study reports on a cluster analysis which identified three clusters of genes with a comparable expression pattern in response to increasing concentrations of betaHCG. Most of the up-regulated genes encoded proteins that are involved in cell adhesion, intercellular communication, extracellular matrix remodelling, apoptosis and inflammation. Stromal monocultures from eight patients, treated with and without 50U/ml of betaHCG, were then incubated and real-time polymerase chain reaction for the highly up-regulated genes PAI2, DUSP6, PLAU and MMP1 performed in order to validate the cDNA array findings in patients with endometriosis. Taken together, this study shows that betaHCG induces dose-dependent characteristic response clusters in the gene expression profile of stromal cells obtained from endometriotic lesions which could explain the differential biological responses of betaHCG in endometriosis.

My notes (saved in your browser only)

MeSH descriptors

Chorionic Gonadotropin, beta Subunit, Human Endometrium Gene Expression Stromal Cells Adult Adult CD56 Antigen CD56 Antigen CD56 Antigen Chorionic Gonadotropin, beta Subunit, Human Chorionic Gonadotropin, beta Subunit, Human Chorionic Gonadotropin, beta Subunit, Human Dose-Response Relationship, Drug Dose-Response Relationship, Drug Endometrium Endometrium Endometrium Endometrium Female Female

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (30)

Cited by (1)

Source provenance

europepmc
last seen: 2026-10-10T06:11:15.153948+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:07:31.877465+00:00
License: CC0 · commercial use OK